4//SEC Filing
Brennan Kevin M. 4
Accession 0001415889-25-000404
CIK 0001840233other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:15 PM ET
Size
11.1 KB
Accession
0001415889-25-000404
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Exercise/Conversion
Common Stock
2025-01-01+5,000→ 5,000 total - Exercise/Conversion
Restricted Stock Units
2025-01-01−5,000→ 15,000 total→ Common Stock (5,000 underlying) - Sale
Common stock
2025-01-02$0.98/sh−1,803$1,774→ 3,197 total - Award
Stock Option (right to buy)
2025-01-01+60,000→ 60,000 totalExercise: $0.95Exp: 2035-12-31→ Common Stock (60,000 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs) convert to stock on a one-for-one basis
- [F2]The reported sale of 1,803 shares occurred automatically in a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2024 solely to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
- [F4]The option was granted on January 1, 2025 and will vest in 48 equal monthly installments beginning on February 1, 2025 and continuing through January 1, 2029.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001971303
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:15 PM ET
- Size
- 11.1 KB